Skip to main content
Erschienen in: Journal of Neurology 8/2012

01.08.2012 | Original Communication

Neurocognitive and atrophic patterns in Parkinson’s disease based on subjective memory complaints

verfasst von: Jin Yong Hong, Ji Eun Lee, Young H. Sohn, Phil Hyu Lee

Erschienen in: Journal of Neurology | Ausgabe 8/2012

Einloggen, um Zugang zu erhalten

Abstract

Ample evidence has suggested that individuals with subjective memory complaints are at a higher risk for cognitive decline. Nevertheless, the significance of subjective memory complaints in Parkinson’s disease has not been studied until now. We investigated whether the patterns of cognitive profiles and gray matter density differed in cognitively normal patients with Parkinson’s disease based on the presence of subjective memory complaints. Using a single question with a yes or no answer, cognitively normal patients with Parkinson’s disease were classified as with (n = 20) or without subjective memory complaints (n = 15). Cognitive profiles and gray matter density were examined using standardized neuropsychological tests and voxel-based morphometry. No significant differences in demographic characteristics were observed between groups. The detailed neuropsychological tests demonstrated that Parkinson’s disease patients with subjective memory complaints had significantly decreased verbal fluency and slightly lower scores on the backward digit-span test compared with those without subjective memory complaints. A voxel-based morphometry analysis revealed that Parkinson’s disease patients with subjective memory complaints had significantly decreased gray matter density in the anterior cingulate gyrus and right inferior parietal lobule compared with those without subjective memory complaints. Our data demonstrated that Parkinson’s disease patients with subjective memory complaints showed a poorer performance on tasks related to verbal fluency and attention with more severe cortical atrophy compared to those without subjective memory complaints, suggesting that subjective memory complaints in patients with Parkinson’s disease may represent an early manifestation of underlying Parkinson’s disease-related pathological changes.
Literatur
1.
Zurück zum Zitat Reid LM, Maclullich AM (2006) Subjective memory complaints and cognitive impairment in older people. Dement Geriatr Cogn Disord 22:471–485PubMedCrossRef Reid LM, Maclullich AM (2006) Subjective memory complaints and cognitive impairment in older people. Dement Geriatr Cogn Disord 22:471–485PubMedCrossRef
2.
Zurück zum Zitat Striepens N, Scheef L, Wind A, Popp J, Spottke A, Cooper-Mahkorn D, Suliman H, Wagner M, Schild HH, Jessen F (2010) Volume loss of the medial temporal lobe structures in subjective memory impairment. Dement Geriatr Cogn Disord 29:75–81PubMedCrossRef Striepens N, Scheef L, Wind A, Popp J, Spottke A, Cooper-Mahkorn D, Suliman H, Wagner M, Schild HH, Jessen F (2010) Volume loss of the medial temporal lobe structures in subjective memory impairment. Dement Geriatr Cogn Disord 29:75–81PubMedCrossRef
3.
Zurück zum Zitat Rodda J, Dannhauser T, Cutinha DJ, Shergill SS, Walker Z (2010) Subjective cognitive impairment: functional MRI during a divided attention task. Eur Psychiatry 26:457–462PubMedCrossRef Rodda J, Dannhauser T, Cutinha DJ, Shergill SS, Walker Z (2010) Subjective cognitive impairment: functional MRI during a divided attention task. Eur Psychiatry 26:457–462PubMedCrossRef
4.
Zurück zum Zitat Barnes LL, Schneider JA, Boyle PA, Bienias JL, Bennett DA (2006) Memory complaints are related to Alzheimer disease pathology in older persons. Neurology 67:1581–1585PubMedCrossRef Barnes LL, Schneider JA, Boyle PA, Bienias JL, Bennett DA (2006) Memory complaints are related to Alzheimer disease pathology in older persons. Neurology 67:1581–1585PubMedCrossRef
5.
6.
Zurück zum Zitat Biggins CA, Boyd JL, Harrop FM, Madeley P, Mindham RH, Randall JI, Spokes EG (1992) A controlled, longitudinal study of dementia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 55:566–571PubMedCrossRef Biggins CA, Boyd JL, Harrop FM, Madeley P, Mindham RH, Randall JI, Spokes EG (1992) A controlled, longitudinal study of dementia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 55:566–571PubMedCrossRef
7.
Zurück zum Zitat de Lau LM, Schipper CM, Hofman A, Koudstaal PJ, Breteler MM (2005) Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch Neurol 62:1265–1269PubMedCrossRef de Lau LM, Schipper CM, Hofman A, Koudstaal PJ, Breteler MM (2005) Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch Neurol 62:1265–1269PubMedCrossRef
8.
Zurück zum Zitat Hobson P, Meara J (2004) Risk and incidence of dementia in a cohort of older subjects with Parkinson’s disease in the United Kingdom. Mov Disord 19:1043–1049PubMedCrossRef Hobson P, Meara J (2004) Risk and incidence of dementia in a cohort of older subjects with Parkinson’s disease in the United Kingdom. Mov Disord 19:1043–1049PubMedCrossRef
9.
Zurück zum Zitat Levy G, Tang MX, Louis ED, Cote LJ, Alfaro B, Mejia H, Stern Y, Marder K (2002) The association of incident dementia with mortality in PD. Neurology 59:1708–1713PubMedCrossRef Levy G, Tang MX, Louis ED, Cote LJ, Alfaro B, Mejia H, Stern Y, Marder K (2002) The association of incident dementia with mortality in PD. Neurology 59:1708–1713PubMedCrossRef
10.
Zurück zum Zitat Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH (2007) Defining mild cognitive impairment in Parkinson’s disease. Mov Disord 22:1272–1277PubMedCrossRef Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH (2007) Defining mild cognitive impairment in Parkinson’s disease. Mov Disord 22:1272–1277PubMedCrossRef
11.
Zurück zum Zitat Janvin CC, Larsen JP, Aarsland D, Hugdahl K (2006) Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia. Mov Disord 21:1343–1349PubMedCrossRef Janvin CC, Larsen JP, Aarsland D, Hugdahl K (2006) Subtypes of mild cognitive impairment in Parkinson’s disease: progression to dementia. Mov Disord 21:1343–1349PubMedCrossRef
12.
Zurück zum Zitat Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75:1062–1069PubMedCrossRef Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75:1062–1069PubMedCrossRef
13.
Zurück zum Zitat Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCrossRef
14.
Zurück zum Zitat Kang Y, Na DL (2003) Seoul Neuropsychological Screening Battery. Human Brain Research and Consulting Co, Incheon Kang Y, Na DL (2003) Seoul Neuropsychological Screening Battery. Human Brain Research and Consulting Co, Incheon
15.
Zurück zum Zitat Lee JE, Park HJ, Park B, Song SK, Sohn YH, Lee JD, Lee PH (2010) A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson’s disease dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 81:320–326PubMedCrossRef Lee JE, Park HJ, Park B, Song SK, Sohn YH, Lee JD, Lee PH (2010) A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson’s disease dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 81:320–326PubMedCrossRef
16.
Zurück zum Zitat Lee JE, Park HJ, Song SK, Sohn YH, Lee JD, Lee PH (2010) Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease. Neurology 75:2009–2016PubMedCrossRef Lee JE, Park HJ, Song SK, Sohn YH, Lee JD, Lee PH (2010) Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease. Neurology 75:2009–2016PubMedCrossRef
17.
Zurück zum Zitat Cho H, Yang DW, Shon YM, Kim BS, Kim YI, Choi YB, Lee KS, Shim YS, Yoon B, Kim W, Ahn KJ (2008) Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study. J Korean Med Sci 23:477–483PubMedCrossRef Cho H, Yang DW, Shon YM, Kim BS, Kim YI, Choi YB, Lee KS, Shim YS, Yoon B, Kim W, Ahn KJ (2008) Abnormal integrity of corticocortical tracts in mild cognitive impairment: a diffusion tensor imaging study. J Korean Med Sci 23:477–483PubMedCrossRef
18.
Zurück zum Zitat Yue NC, Arnold AM, Longstreth WT Jr, Elster AD, Jungreis CA, O’Leary DH, Poirier VC, Bryan RN (1997) Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study. Radiology 202:33–39PubMed Yue NC, Arnold AM, Longstreth WT Jr, Elster AD, Jungreis CA, O’Leary DH, Poirier VC, Bryan RN (1997) Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study. Radiology 202:33–39PubMed
19.
Zurück zum Zitat Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedCrossRef Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571PubMedCrossRef
20.
Zurück zum Zitat Sollinger AB, Goldstein FC, Lah JJ, Levey AI, Factor SA (2010) Mild cognitive impairment in Parkinson’s disease: subtypes and motor characteristics. Parkinsonism Relat Disord 16:177–180PubMedCrossRef Sollinger AB, Goldstein FC, Lah JJ, Levey AI, Factor SA (2010) Mild cognitive impairment in Parkinson’s disease: subtypes and motor characteristics. Parkinsonism Relat Disord 16:177–180PubMedCrossRef
21.
Zurück zum Zitat Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533–1539PubMedCrossRef Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533–1539PubMedCrossRef
22.
Zurück zum Zitat Levy G, Jacobs DM, Tang MX, Cote LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K (2002) Memory and executive function impairment predict dementia in Parkinson’s disease. Mov Disord 17:1221–1226PubMedCrossRef Levy G, Jacobs DM, Tang MX, Cote LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K (2002) Memory and executive function impairment predict dementia in Parkinson’s disease. Mov Disord 17:1221–1226PubMedCrossRef
23.
Zurück zum Zitat Jacobs DM, Marder K, Cote LJ, Sano M, Stern Y, Mayeux R (1995) Neuropsychological characteristics of preclinical dementia in Parkinson’s disease. Neurology 45:1691–1696PubMedCrossRef Jacobs DM, Marder K, Cote LJ, Sano M, Stern Y, Mayeux R (1995) Neuropsychological characteristics of preclinical dementia in Parkinson’s disease. Neurology 45:1691–1696PubMedCrossRef
24.
Zurück zum Zitat Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324PubMedCrossRef Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324PubMedCrossRef
25.
Zurück zum Zitat Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA (2009) The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort. Brain 132:2958–2969PubMedCrossRef Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA (2009) The distinct cognitive syndromes of Parkinson’s disease: 5 year follow-up of the CamPaIGN cohort. Brain 132:2958–2969PubMedCrossRef
26.
Zurück zum Zitat Kehagia AA, Barker RA, Robbins TW (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease. Lancet Neurol 9:1200–1213PubMedCrossRef Kehagia AA, Barker RA, Robbins TW (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson’s disease. Lancet Neurol 9:1200–1213PubMedCrossRef
27.
Zurück zum Zitat Rinne JO, Portin R, Ruottinen H, Nurmi E, Bergman J, Haaparanta M, Solin O (2000) Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch Neurol 57:470–475PubMedCrossRef Rinne JO, Portin R, Ruottinen H, Nurmi E, Bergman J, Haaparanta M, Solin O (2000) Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch Neurol 57:470–475PubMedCrossRef
28.
Zurück zum Zitat Sawamoto N, Piccini P, Hotton G, Pavese N, Thielemans K, Brooks DJ (2008) Cognitive deficits and striato-frontal dopamine release in Parkinson’s disease. Brain 131:1294–1302PubMedCrossRef Sawamoto N, Piccini P, Hotton G, Pavese N, Thielemans K, Brooks DJ (2008) Cognitive deficits and striato-frontal dopamine release in Parkinson’s disease. Brain 131:1294–1302PubMedCrossRef
29.
Zurück zum Zitat Jokinen P, Bruck A, Aalto S, Forsback S, Parkkola R, Rinne JO (2009) Impaired cognitive performance in Parkinson’s disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord 15:88–93PubMedCrossRef Jokinen P, Bruck A, Aalto S, Forsback S, Parkkola R, Rinne JO (2009) Impaired cognitive performance in Parkinson’s disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord 15:88–93PubMedCrossRef
30.
Zurück zum Zitat Abrahams S, Goldstein LH, Simmons A, Brammer MJ, Williams SC, Giampietro VP, Andrew CM, Leigh PN (2003) Functional magnetic resonance imaging of verbal fluency and confrontation naming using compressed image acquisition to permit overt responses. Hum Brain Mapp 20:29–40PubMedCrossRef Abrahams S, Goldstein LH, Simmons A, Brammer MJ, Williams SC, Giampietro VP, Andrew CM, Leigh PN (2003) Functional magnetic resonance imaging of verbal fluency and confrontation naming using compressed image acquisition to permit overt responses. Hum Brain Mapp 20:29–40PubMedCrossRef
31.
Zurück zum Zitat Pihlajamaki M, Tanila H, Hanninen T, Kononen M, Laakso M, Partanen K, Soininen H, Aronen HJ (2000) Verbal fluency activates the left medial temporal lobe: a functional magnetic resonance imaging study. Ann Neurol 47:470–476PubMedCrossRef Pihlajamaki M, Tanila H, Hanninen T, Kononen M, Laakso M, Partanen K, Soininen H, Aronen HJ (2000) Verbal fluency activates the left medial temporal lobe: a functional magnetic resonance imaging study. Ann Neurol 47:470–476PubMedCrossRef
32.
Zurück zum Zitat Pereira JB, Junque C, Marti MJ, Ramirez-Ruiz B, Bartres-Faz D, Tolosa E (2009) Structural brain correlates of verbal fluency in Parkinson’s disease. Neuroreport 20:741–744PubMedCrossRef Pereira JB, Junque C, Marti MJ, Ramirez-Ruiz B, Bartres-Faz D, Tolosa E (2009) Structural brain correlates of verbal fluency in Parkinson’s disease. Neuroreport 20:741–744PubMedCrossRef
33.
Zurück zum Zitat Phelps EA, Hyder F, Blamire AM, Shulman RG (1997) FMRI of the prefrontal cortex during overt verbal fluency. Neuroreport 8:561–565PubMedCrossRef Phelps EA, Hyder F, Blamire AM, Shulman RG (1997) FMRI of the prefrontal cortex during overt verbal fluency. Neuroreport 8:561–565PubMedCrossRef
34.
Zurück zum Zitat Raichle ME, Fiez JA, Videen TO, MacLeod AM, Pardo JV, Fox PT, Petersen SE (1994) Practice-related changes in human brain functional anatomy during nonmotor learning. Cereb Cortex 4:8–26PubMedCrossRef Raichle ME, Fiez JA, Videen TO, MacLeod AM, Pardo JV, Fox PT, Petersen SE (1994) Practice-related changes in human brain functional anatomy during nonmotor learning. Cereb Cortex 4:8–26PubMedCrossRef
35.
Zurück zum Zitat Pardo JV, Pardo PJ, Janer KW, Raichle ME (1990) The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. Proc Natl Acad Sci USA 87:256–259PubMedCrossRef Pardo JV, Pardo PJ, Janer KW, Raichle ME (1990) The anterior cingulate cortex mediates processing selection in the Stroop attentional conflict paradigm. Proc Natl Acad Sci USA 87:256–259PubMedCrossRef
36.
Zurück zum Zitat Corbetta M, Shulman GL (2002) Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci 3:201–215PubMedCrossRef Corbetta M, Shulman GL (2002) Control of goal-directed and stimulus-driven attention in the brain. Nat Rev Neurosci 3:201–215PubMedCrossRef
37.
Zurück zum Zitat Dujardin K, Duhamel A, Delliaux M, Thomas-Anterion C, Destee A, Defebvre L (2010) Cognitive complaints in Parkinson’s disease: its relationship with objective cognitive decline. J Neurol 257:79–84PubMedCrossRef Dujardin K, Duhamel A, Delliaux M, Thomas-Anterion C, Destee A, Defebvre L (2010) Cognitive complaints in Parkinson’s disease: its relationship with objective cognitive decline. J Neurol 257:79–84PubMedCrossRef
38.
Zurück zum Zitat Petrova M, Raycheva M, Zhelev Y, Traykov L (2010) Executive functions deficit in Parkinson’s disease with amnestic mild cognitive impairment. Am J Alzheimers Dis Other Demen 25:455–460PubMedCrossRef Petrova M, Raycheva M, Zhelev Y, Traykov L (2010) Executive functions deficit in Parkinson’s disease with amnestic mild cognitive impairment. Am J Alzheimers Dis Other Demen 25:455–460PubMedCrossRef
39.
Zurück zum Zitat Mattos P, Lino V, Rizo L, Alfano A, Araujo C, Raggio R (2003) Memory complaints and test performance in healthy elderly persons. Arq Neuropsiquiatr 61:920–924PubMedCrossRef Mattos P, Lino V, Rizo L, Alfano A, Araujo C, Raggio R (2003) Memory complaints and test performance in healthy elderly persons. Arq Neuropsiquiatr 61:920–924PubMedCrossRef
Metadaten
Titel
Neurocognitive and atrophic patterns in Parkinson’s disease based on subjective memory complaints
verfasst von
Jin Yong Hong
Ji Eun Lee
Young H. Sohn
Phil Hyu Lee
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 8/2012
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-011-6404-3

Weitere Artikel der Ausgabe 8/2012

Journal of Neurology 8/2012 Zur Ausgabe

Original Communication

Inferior vestibular neuritis

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.